Երկիր: Ամերիկայի Միացյալ Նահանգներ
Լեզու: անգլերեն
Աղբյուրը: NLM (National Library of Medicine)
Ciclopirox Olamine (UNII: 50MD4SB4AP) (Ciclopirox - UNII:19W019ZDRJ)
Taro Pharmaceuticals U.S.A., Inc.
Ciclopirox Olamine
Ciclopirox 7.7 mg in 1 mL
TOPICAL
PRESCRIPTION DRUG
Ciclopirox Topical Suspension USP is indicated for the topical treatment of the following dermal infections: tinea pedis, tinea cruris, and tinea corporis due to Trichophyton rubrum , Trichophyton mentagrophytes , Epidermophyton floccosum , and Microsporum canis ; cutaneous candidiasis (moniliasis) due to Candida albicans ; and tinea (pityriasis) versicolor due to Malassezia furfur . Ciclopirox Topical Suspension USP is contraindicated in individuals who have shown hypersensitivity to any of its components.
Ciclopirox Topical Suspension USP, 0.77% is supplied in 30 mL (NDC 51672-1323-3) and 60 mL (NDC 51672-1323-4) bottles. Bottle space provided to allow for vigorous shaking before each use. Store at 20°-25°C (68°-77°F) [see USP Controlled Room Temperature].
Abbreviated New Drug Application
CICLOPIROX- CICLOPIROX SUSPENSION TARO PHARMACEUTICALS U.S.A., INC. ---------- CICLOPIROX TOPICAL SUSPENSION USP, 0.77% W/W RX ONLY FOR DERMATOLOGIC USE ONLY NOT FOR OPHTHALMIC USE DESCRIPTION Ciclopirox Topical Suspension USP, 0.77% is for topical use. Each gram of Ciclopirox Topical Suspension USP contains 7.70 mg of ciclopirox (as ciclopirox olamine) in a water miscible suspension base consisting of cetyl alcohol, cocamide DEA, lactic acid, mineral oil, myristyl alcohol, octyldodecanol, polysorbate 60, purified water, sorbitan monostearate, stearyl alcohol, and benzyl alcohol (1%) as preservative. Ciclopirox Topical Suspension USP contains a synthetic, broad-spectrum, antifungal agent ciclopirox (as ciclopirox olamine). The chemical name is 6-cyclohexyl-1-hydroxy-4-methyl-2(1_H_)-pyridone, 2- aminoethanol salt. The CAS Registry Number is 41621-49-2. The chemical structure is: Ciclopirox Topical Suspension USP has a pH of 7. CLINICAL PHARMACOLOGY Ciclopirox is a broad-spectrum, antifungal agent that inhibits the growth of pathogenic dermatophytes, yeasts, and _Malassezia furfur_. Ciclopirox exhibits fungicidal activity _in vitro_ against isolates of _Trichophyton rubrum_, _Trichophyton mentagrophytes_, _Epidermophyton floccosum_, _Microsporum canis_, and _Candida albicans_. Pharmacokinetic studies in men with radiolabeled ciclopirox solution in polyethylene glycol 400 showed an average of 1.3% absorption of the dose when it was applied topically to 750 cm on the back followed by occlusion for 6 hours. The biological half-life was 1.7 hours and excretion occurred via the kidney. Two days after application only 0.01% of the dose applied could be found in the urine. Fecal excretion was negligible. Autoradiographic studies with human cadaver skin showed that ciclopirox penetrates into the hair and through the epidermis and hair follicles into the sebaceous glands and dermis, while a portion of the drug remains in the stratum corneum. 2 _In vitro_ penetration studies in frozen or fresh excised human cadaver and pig Կարդացեք ամբողջական փաստաթուղթը